Biotech · Private company

Target Health Inc.

Track this companyFree. Adds Target Health Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials40 recruiting or active

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Clinical trials4

NRX-101 for Maintenance of Remission From Severe Bipolar Depression in Patients With Suicidal IdeationPHASE3 · UNKNOWN · started Dec 1, 2019ClinicalTrials.gov NCT03396068 · fetched Nov 12, 2026
NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar DepressionPHASE3 · UNKNOWN · started Jun 25, 2019ClinicalTrials.gov NCT03396601 · fetched Nov 12, 2026
NRX101 Glx Biomarker Validation StudyPHASE2_PHASE3 · COMPLETED · started Nov 1, 2018ClinicalTrials.gov NCT03402152 · fetched Nov 12, 2026
Sequential Therapy for the Treatment of Severe Bipolar Depression.PHASE2 · COMPLETED · started Jan 15, 2018ClinicalTrials.gov NCT02974010 · fetched Nov 12, 2026